IHS Chemical Week

Regions :: Western Europe :: Denmark

Novozymes Sales and Profits Grow Strongly in 2010

4:45 AM MST | January 24, 2011 | Alex Scott

Enzymes technology company Novozymes (Copenhagen) says its 2010 Ebit increased 25% to DK 2.1 billion ($382 million) on sales up 15% to DK 9.7 billion. Overall demand was high in the enzyme business, and costs were kept under control, the company says.   The outlook for 2011 is for an Ebit growth of 8-11% with a corresponding growth in sales of 7-11%. ROIC was 22.2% in 2010, compared with 20.3% in 2009, including goodwill.   “We performed very well in terms of sales, earnings, cash flow, and sustainability," says Steen Riisgaard...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa